Fibromyalgia is defined by widespread pain, fatigue, cognitive difficulties (“fibro fog”), and sleep disturbance — yet routine blood tests, imaging, and biopsies are typically normal. This absence of clear peripheral pathology has led researchers to look at central nervous system mechanisms, and one consistent finding is that people with fibromyalgia show reduced vagal tone. Whether this is a cause, a consequence, or a parallel feature of the condition is still debated, but the evidence for autonomic dysfunction in fibromyalgia is now substantial enough to shape both research and emerging treatment strategies.
The Autonomic Profile of Fibromyalgia
Multiple studies have documented a characteristic autonomic pattern in fibromyalgia: reduced parasympathetic (vagal) activity with relatively increased sympathetic dominance. A 2014 meta-analysis by Tak and colleagues in Psychosomatic Medicine examined HRV across 33 studies and found that fibromyalgia patients had significantly lower HF-HRV (the frequency-domain index of vagal tone) and lower RMSSD (the time-domain equivalent) compared to healthy controls.
This autonomic shift is not subtle. The effect sizes are comparable to those seen in other conditions characterised by autonomic dysfunction, such as chronic fatigue syndrome and POTS (postural orthostatic tachycardia syndrome) — conditions that overlap clinically with fibromyalgia so frequently that some researchers consider them part of a shared spectrum of central sensitisation disorders.
The clinical manifestations of this autonomic imbalance go beyond pain: orthostatic intolerance (lightheadedness on standing), irritable bowel syndrome, bladder dysfunction, dry eyes and mouth, temperature dysregulation, and resting tachycardia are all commonly reported by fibromyalgia patients and are consistent with reduced vagal influence on their respective organ systems.
Central Sensitisation and Descending Pain Modulation
The core mechanism in fibromyalgia appears to be central sensitisation — an amplification of pain signalling within the spinal cord and brain that makes normally innocuous stimuli painful (allodynia) and painful stimuli more intense (hyperalgesia). Functional MRI studies have shown that fibromyalgia patients have increased activation in pain-processing regions (insula, anterior cingulate cortex, somatosensory cortex) in response to stimuli that produce no pain response in controls.
Descending pain modulation — the brain’s ability to suppress incoming pain signals at the spinal cord level — is impaired in fibromyalgia. The brainstem nuclei involved in this descending inhibition (periaqueductal grey, rostral ventromedial medulla, locus coeruleus) use serotonin and norepinephrine as their primary neurotransmitters, which is why serotonin-norepinephrine reuptake inhibitors (SNRIs like duloxetine and milnacipran) are among the few pharmacological treatments with evidence in fibromyalgia.
The vagus nerve connects to this system through the nucleus tractus solitarius (NTS), which receives vagal afferent input and projects to many of these same brainstem pain-modulation centres. Reduced vagal afferent signalling could theoretically weaken descending inhibition, contributing to the pain amplification seen in fibromyalgia. This is a plausible mechanism but remains a hypothesis rather than an established causal pathway.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
The Cholinergic Anti-Inflammatory Pathway
Kevin Tracey’s discovery of the inflammatory reflex showed that vagal efferents can suppress systemic inflammation through the cholinergic anti-inflammatory pathway: vagal signals activate the splenic nerve, which releases norepinephrine in the spleen, stimulating acetylcholine release from specialised T cells, which in turn suppresses TNF-alpha and other pro-inflammatory cytokines from macrophages.
Fibromyalgia has been associated with low-grade neuroinflammation — elevated cerebrospinal fluid levels of substance P, IL-6, and IL-8 — and a PET study by Albrecht and colleagues (2019, Brain, Behavior, and Immunity) found increased glial activation in the brains of fibromyalgia patients. If vagal anti-inflammatory control is impaired, this could permit or sustain the neuroinflammatory state. However, the relationship between peripheral vagal tone (measured by HRV) and central neuroinflammation is indirect, and the evidence linking them specifically in fibromyalgia is preliminary.
Small Fibre Neuropathy: A Peripheral Component
A finding that has complicated the “purely central” model of fibromyalgia is the discovery that roughly 40–60% of fibromyalgia patients have reduced intraepidermal nerve fibre density on skin biopsy — diagnostic of small fibre neuropathy (SFN). This was first reported by Oaklander and colleagues (2013, Pain) and has been replicated in multiple cohorts.
Small fibres include the C-fibres and A-delta fibres that carry pain, temperature, and autonomic signals. Their degeneration could contribute to both the pain and the autonomic dysfunction seen in fibromyalgia. The vagus nerve itself contains predominantly unmyelinated C-fibres (roughly 80% of its fibres are sensory afferents), and whether small fibre pathology extends to the vagus nerve in fibromyalgia has not been directly studied but is an active area of investigation. Corneal confocal microscopy — a non-invasive measure of small fibre density in the cornea — has shown reduced fibre density in fibromyalgia patients, supporting a systemic small fibre process.
Vagus Nerve Stimulation for Fibromyalgia
Given the evidence for reduced vagal tone, vagus nerve stimulation has been explored as a fibromyalgia treatment. The evidence is early-stage but worth understanding:
Invasive VNS. There are no large randomised trials of implanted VNS devices for fibromyalgia. A small pilot study by Lange and colleagues (2011) showed some benefit, but the sample size was too small for conclusions.
Transcutaneous VNS (tVNS). Non-invasive auricular tVNS has been tested in several small trials. A 2022 randomised sham-controlled trial by Kutlu and colleagues found that 4 weeks of daily auricular tVNS produced modest reductions in pain severity and improvements in sleep quality compared to sham stimulation. However, the effects were moderate, and larger multicentre trials are needed before tVNS can be recommended as a standard fibromyalgia treatment.
Self-directed vagal practices. Slow breathing at 5–6 breaths per minute has been shown to acutely increase HRV in fibromyalgia patients, and two small trials found that 8–12 weeks of daily slow-breathing practice improved pain scores and sleep quality. These studies were not blinded (it is difficult to blind breathing interventions), but the low risk and zero cost make slow breathing a reasonable adjunctive practice.
What This Means in Practice
Fibromyalgia is not caused by a single vagus nerve malfunction — it is a complex condition involving central sensitisation, autonomic dysregulation, possible neuroinflammation, and in many cases peripheral small fibre pathology. Reduced vagal tone is a consistent finding that reflects one dimension of this complexity. It may contribute to the condition through impaired pain modulation and reduced anti-inflammatory signalling, or it may be a downstream consequence of chronic pain and poor sleep, which themselves reduce vagal tone.
Either way, the clinical implication is the same: practices that support vagal function — regular aerobic exercise (the strongest evidence base in fibromyalgia management), slow breathing, adequate sleep, and stress reduction — are unlikely to resolve fibromyalgia on their own but may improve the autonomic component of the symptom burden.
Fibromyalgia’s connection to the vagus nerve is part of a larger story about how autonomic function shapes chronic conditions. Get the Vagus Nerve & Me eBook for a clear, evidence-based guide to the nerve that connects it all.
